University of Arizona: Breast Neoplasms trials

The registry lists 29 Breast Neoplasms studies with University of Arizona as lead sponsor. 1 are open to participants now and 8 have results posted.

Early Phase 1 3Phase 1 4Phase 2 10No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• High-Resolution Lower Dose Dedicated Breast Computed Tomography (CT)RecruitingNCT03954431Not applicable
• Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer PatientsCompletedNCT03847311Phase 2Results posted
• T-DM1 and Palbociclib for Metastatic HER2 Breast CancerCompletedNCT03530696Phase 2Results posted
• Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer RiskCompletedNCT02028221Phase 2Results posted
• Correlate BRCA1 Protein Expression With Response to DNA Damaging ChemotherapyTerminatedNCT01990352Phase 2Results posted
• Estradiol Levels in Patients Treated With EstringCompletedNCT01923298Phase 2Results posted
• Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast CancerTerminatedNCT01394211Phase 2Results posted
• Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast CancerCompletedNCT01385280Not applicableResults posted
• Irinotecan and Etoposide in Treating Patients With Recurrent, Locally Advanced, or Metastatic Breast CancerCompletedNCT00693719Phase 2Results posted
• Impact of Osteopathic Manipulative Medicine on Sentinal Lymph Node Biopsy Dye and Tracer UptakeCompletedNCT07269860Not applicable
• Adaptive Symptom Self-Management Immunotherapy StudyActive, not recruitingNCT05715255Not applicable
• Evaluation of Hydroxychloroquine to Prevent CIPNWithdrawnNCT05689359Phase 2
• Novel Thermal Imaging Technique for Breast ScreeningTerminatedNCT05650086
• Prospective Comparison of Breast MRI vs Contrast Mammography Prior to Surgery in Breast Cancer PatientsWithdrawnNCT04770714Not applicable
• Epigenetics of TNBC in Overweight and Obese Hispanic & Non-Hispanic White WomenWithdrawnNCT04291950
• Window of Opportunity Trial, PARP Inhibitor Rucaparib Affect on PD-L1 Expression in Triple Negative Breast TumorsCompletedNCT03911453Early Phase 1
• Weight Bearing Exercise in Preventing Frailty in Stage I-IIIA Breast Cancer SurvivorsCompletedNCT03708055Not applicable
• Pilot, Syndros, Decreasing Use of Opioids in Breast Cancer Subjects With Bone MetsCompletedNCT03661892Early Phase 1
• Diffusion Tensor Imaging in Predicting Development of Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer (CIPN)CompletedNCT03365895Not applicable
• An Early Phase Clinical Trial to Evaluate the Feasibility of CEST MRI in Patients With Early Stage Breast CancerTerminatedNCT02380209Early Phase 1
• Epidemiological Analysis of Vitamin D and Breast Cancer Risk in Saudi Arabian WomenCompletedNCT01817231
• Human Breast Tissue Bioavailability of Topically Applied LimoneneCompletedNCT01459172Phase 1
• Diindolylmethane in Treating Patients With Breast CancerCompletedNCT01391689Not applicable
• Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast CancerCompletedNCT01288261Phase 1
• Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid TumorsCompletedNCT01172028Phase 1
• Limonene Study in Women With Breast CancerCompletedNCT01046929Phase 1
• Studying Blood Samples in Women With Breast Cancer or a History of Breast CancerCompletedNCT00898703
• Acupuncture or Medication in Reducing Pain in Postmenopausal Women With Breast Cancer and Joint PainTerminatedNCT00892268Phase 2
• High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast CancerCompletedNCT00003068Phase 2